Search results for "Alzheimer's Disease"


 
Results 1 - 10 of about 58 for "Alzheimer's Disease".
Sort by: Relevance | Newest | Oldest

OTC birth control pill, naloxone gain approval

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023

Adults with subjective cognitive decline were more likely to report 4 modifiable risk factors for Alzheimer's disease

Among survey respondents ages 45 years and older, the most common modifiable risk factor for Alzheimer's disease and related dementias was hypertension (49.9%), followed by not meeting guidelines for aerobic physical activity (49.7%), obesity (35.3%), and diabetes (18.6%).
https://immattersacp.org/weekly/archives/2022/05/31/2.htm
31 May 2022

Finances can offer clues to cognitive problems

A study found that patients with Alzheimer's disease and related dementias were more likely to miss payments on credit accounts as early as six years before diagnosis and to develop subprime credit scores 2.5 years before diagnosis.
https://immattersacp.org/archives/2022/05/finances-can-offer-clues-to-cognitive-problems.htm
1 May 2022

Menopausal hormone therapy not associated with increased dementia risk

The findings of this retrospective study in the United Kingdom should reassure women taking menopausal hormonal therapy but do not support its use to prevent dementia, a linked opinion piece said.
https://immattersacp.org/weekly/archives/2021/10/05/5.htm
5 Oct 2021

What's in an eponym? Discussing namesake diseases

Where do medical eponyms come from? Consider their origins, the reasons why they've fallen out of favor, and why some still, against the odds, endure.
https://immattersacp.org/archives/2021/03/whats-in-an-eponym-discussing-namesake-diseases.htm
1 Mar 2021

Inappropriate medications prescribed in some Medicare patients with CKD, study finds

Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021

New warnings on benzodiazepines

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/11/new-warnings-on-benzodiazepines.htm
1 Nov 2020

Extended-release metformin recalled due to impurity

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/07/extended-release-metformin-recalled-due-to-impurity.htm
1 Jul 2020

Dementia care poses ethical quagmires

Dementia presents unique ethical challenges for physicians because it is a “disease of autonomy.”
https://immattersacp.org/archives/2020/05/dementia-care-poses-ethical-quagmires.htm
1 May 2020

Systematic reviews examine Alzheimer's detection, biomarkers, pharmacological treatments

An accompanying editorial noted that while some tools are available to identify, diagnose, and treat cognitive dysfunction from Alzheimer's dementia, they are blunt and lack clinical utility.
https://immattersacp.org/weekly/archives/2020/04/28/2.htm
28 Apr 2020

Result Page: Prev   1   2   3   4   5   6   Next